Innovations in idiopathic pulmonary fibrosis

Thematic Poster
Chairs: C. Moor (Rotterdam, Netherlands), W. Wuyts (Rotselaar, Belgium), J. Wälscher (Essen, Germany), P. Molyneaux (London, United Kingdom)

Correlation between home and clinic spirometry in subjects with IPF: results from the INMARK trial T. Maher (London, United Kingdom), V. Cottin (Lyon, France), A. Russell (London, United Kingdom), T. Corte (New South Wales, Australia), P. Hammerl (Immenhausen, Germany), A. Michael (Farnborough, United Kingdom), K. Rohr (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), S. Stowasser (Ingelheim am Rhein, Germany), I. Noth (Charlottesville, Virginia, United States of America)
No association between Human herpes virus, Herpes virus Saimiri and idiopathic pulmonary fibrosis Q. Le Hingrat (Paris, France), M. Ghanem (Paris, France), A. Cazes (Paris, France), B. Visseaux (Paris, France), G. Collin (Paris, France), D. Descamps (Paris, France), C. Charpentier (Paris, France), B. Crestani (Paris, France)
Development of a patient reported experience measure (PREM) for idiopathic pulmonary fibrosis (IPF) A. Russell (London, United Kingdom), A. Datta (London, United Kingdom), K. Newell (Surrey, United Kingdom), S. Jones (Lichfield, United Kingdom), J. Conway (London, United Kingdom), L. Saktkoo (New Orlean, United States of America), M. Wickremasinghe (London, United Kingdom)
PRAISE IPF study correlation between quantitative lung fibrosis (QLF) measured by quantitative high resolution computed tomography (qHRCT) and quality of life (QoL) assessed by St. George’s respiratory questionnaire (SGRQ) E. Kouchakji (San Francisco, United States of America), J. Goldin (Los Angeles, United States of America), G. Kim (Los Angeles, United States of America), P. Yu (San Francisco, United States of America), M. Zhong (San Francisco, United States of America), D. Zhou (San Francisco, United States of America), T. Sekayan (San Francisco, United States of America)
Lymphoid follicles are a prominent feature in Idiopathic Pulmonary Fibrosis (IPF) lungs. E. Cocconcelli (Padova, Italy), E. Bazzan (Padova, Italy), D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), F. Calabrese (Padova, Italy), F. Rea (Padova, Italy), P. Spagnolo (Padova, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy), G. Turato (Padova, Italy)
Safety and learning curve for Transbronchial Lung Cryobiopsy T. Niwa (Yokohama, Japan), T. Baba (Yokohama, Japan), K. Murotani (Kurume, Japan), E. Tabata (Yokohama, Japan), R. Shintani (Yokohama, Japan), S. Ikeda (Yokohama, Japan), H. Okabayashi (Yokohama, Japan), T. Oda (Yokohama, Japan), R. Okuda (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), S. Komatsu (Yokohama, Japan), E. Hagiwara (Yokohama, Japan), T. Ogura (Yokohama, Japan)
Prevalence and characterization of interstitial lung disease in a lung cancer screening program R. Calzado Lopez (MADRID, Spain), C. Gotera Rivera (MADRID, Spain), T. Pérez Warnisher (MADRID, Spain), R. Melchor Iñiguez (MADRID, Spain), J. Pinillos Robles (MADRID, Spain), E. Cabezas Pastor (MADRID, Spain), A. El Hachem Debek (MADRID, Spain), M. Rodríguez Guzmán (MADRID, Spain), P. Lazo Meneses (MADRID, Spain), J. Alfayate Sánchez (MADRID, Spain), N. González Mangado (MADRID, Spain), G. Peces Barba (MADRID, Spain), L. Seijo Maceiras (MADRID, Spain)
Prediction of IPF Progression Using HRCT Imaging Patterns in Elderly Population J. Song (Seoul, Republic of Korea), G. Kim (Los Angeles, United States of America), S. Weigt (Los Angeles, United States of America), L. Pourzand (Los Angeles, United States of America), W. Hsu (Los Angeles, United States of America), Y. Shi (Los Angeles, United States of America), M. Brown (Los Angeles, United States of America), J. Goldin (Los Angeles, United States of America)
The lower airways microbiome in patients with IPF and COPD K. Knudsen (Bergen, Norway), R. Nielsen (Bergen, Norway), I. Haaland (Bergen, Norway), S. Lehmann (Bergen, Norway), T. Eagan (Bergen, Norway)
Longitudinal high-resolution computed tomography (HRCT) assessment and disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic therapy E. Balestro (Padova, Italy), E. Cocconcelli (Padova, Italy), C. Giraudo (Padova, Italy), D. Biondini (Padova, Italy), R. Polverosi (Padova, Italy), L. Mazzai (Padova, Italy), G. Rizzon (Padova, Italy), E. Quaia (Padova, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy)
Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach C. Landi (Siena, Italy), P. Cameli (Siena, Italy), L. Bergantini (Siena, Italy), M. D'Alessandro (Siena, Italy), L. Bianchi (Siena, Italy), E. Shaba (Siena, Italy), P. Rottoli (Siena, Italy), L. Bini (Siena, Italy), E. Bargagli (Siena, Italy)
Effect of delayed secondary care referral on morbidity and mortality in idiopathic pulmonary fibrosis patients treated with antifibrotics H. Wu (Lancaster, United Kingdom), S. Mahmoud (Lancaster, United Kingdom), T. Gatheral (Lancaster, United Kingdom)
Comparison between Bronchoscopic lung Cryobiopsy and Surgical Lung biopsy in the diagnosis of Idiopathic Pulmonary fibrosis: our experience on 203 cases. S. Sanna (Forli, Italy), D. Argnani (Forli, Italy), M. Mengozzi (Forli, Italy), A. Parisi (Forli, Italy), C. Gurioli (Forli, Italy), V. Poletti (Forli, Italy), F. Stella (Forli, Italy)
Fatigue changes in IPF patients measured by the Fatigue Assessment Scale during antifibrotic treatment L. Kølner-Augustson (Aarhus, Denmark), T. Skovhus Prior (Aarhus, Denmark), V. Skivild (Aarhus, Denmark), A. Aalestrup (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark)
Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema H. Nakagawa (Shiga, Japan), K. Fukunaga (Shiga, Japan), S. Ikeda (Kanagawa, Japan), R. Okuda (Kanagawa, Japan), H. Kitamura (Kanagawa, Japan), T. Baba (Kanagawa, Japan), Y. Nakano (Shiga, Japan), T. Ogura (Kanagawa, Japan)
STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) J. Swigris (Denver, United States of America), S. Nathan (Falls Church, United States of America), R. Tighe (Durham, United States of America), S. Nagra (Palo Alto, United States of America), C. Rabe (South San Francisco, United States of America), D. Kelkhoff (South San Francisco, United States of America), T. Switzer (South San Francisco, United States of America), N. Kolatkar (South San Francisco, United States of America), P. Belloni (South San Francisco, United States of America), J. Golden (San Francisco, United States of America)
Association between weight loss and decline in FVC in patients with IPF B. Crestani (Paris, France), V. Cottin (Lyon , France), R. Thibault (Rennes, France), M. Lederlin (Rennes, France), L. Vernhet (Rennes, France), W. Stansen (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), S. Jouneau (Rennes, France)
Interim analysis of patients with ILD enrolled in the STARLINER study M. Wijsenbeek (Rotterdam, Netherlands), E. Bendstrup (Aarhus, Denmark), C. Valenzuela (Madrid, Spain), M. Henry (Cork, Ireland), C. Moor (Rotterdam, Netherlands), S. Jouneau (Rennes, France), A. Fois (Sassari, Italy), O. Moran (Kingston, Ontario, Canada), S. Anees (Windsor, Ontario, Canada), M. Mirt (Basel, Switzerland), M. Bengus (Basel, Switzerland), F. Gilberg (Basel, Switzerland), K. Kirchgaessler (Basel, Switzerland), C. Vancheri (Catania, Italy)
Significance of small airway obstruction in patients with idiopathic pulmonary fibrosis. Y. Goto (Fukuoka, Japan), K. Tobino (Fukuoka, Japan), M. Okahisa (Fukuoka, Japan)
Low fat-free mass and body mass index are associated with worse survival in patients with idiopathic pulmonary fibrosis (IPF) S. Jouneau (Rennes, France), C. Rousseau (Rennes, France), M. Lederlin (Rennes, France), M. Kerjouan (Rennes, France), T. Guy (Vannes, France), L. Sohier (Lorient, France), A. Salé (Rennes, France), S. Guillot (Rennes, France), L. Vernhet (Rennes, France), E. Oger (Rennes, France), R. Thibault (Rennes, France)